The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.
Interleukin‐10, Polymorphism in SLC11A1(formerly NRAMP1), and Susceptibility to Tuberculosis
Abstract
Host genetic factors are major determinants of susceptibility to tuberculosis, and an understanding of the molecular basis of this observation has major implications for the development of novel therapies and vaccines. Slc11a1 (formerly Nramp1), the first murine infection susceptibility locus identified, regulates early innate responses to intracellular pathogens. Variation in the human homologue SLC11A1 is associated with and linked to tuberculosis in genetically different populations. In a case-control study of 329 tuberculosis case patients and 324 control subjects, the association between allele 2 of a functional SLC11A1 polymorphism and tuberculosis has been reproduced. This variant is associated with higher lipopolysaccharide-induced production of the macrophage-deactivating cytokine interleukin-10. Furthermore, monocytes from persons who develop tuberculosis innately produce more interleukin-10 than do monocytes from healthy control subjects. These data therefore confirm the importance of SLC11A1 in tuberculosis susceptibility in humans and suggest that SLC11A1 influences tuberculosis susceptibility by regulation of interleukin-10.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In both humans and mice, the function of NRAMP1 affects the balance between proinflammatory mediators such as TNF and IFN-γ and antiinflammatory ones such as IL-10 towards adequate production of the former (Awomoyi et al., 2002;Fritsche et al., 2003Fritsche et al., , 2008;;Kovarova et al., 2000).”
From Iron in infection and immunity (2020) · cites this paper as Awomoyi et al., 2002
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684
Ashburner, M. (1989) · Cold Spring Harbor Laboratory eBooks · Cited by 6,756
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S. K., Wise, R. P., Mirabile‐Levens, E., Kasznica, J. M., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,683
Malefyt, R. D. W., Haanen, J. B. A. G., Spits, H., Roncarolo, M., Velde, A. A. T., Figdor, C. G., Johnson, K., KASTELEIN, R. A., Yssel, H., & de Vries, J. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Macrophage deactivation by interleukin 10.
Bogdan, C., Yoram Vodovotz, B., & Nathan, C. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,236
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,198
Self-citationNatural resistance to infection with intracellular parasites: isolation of a candidate for Bcg
Vidal, S. M., Malo, D., Vogan, K., Skamene, E., & Gros, P. (1993) · Cell · doi:10.1016/0092-8674(93)90135-d · Cited by 1,104
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 1,006
Cited by
Sorted by citations
The Immune Response in Tuberculosis
O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,400
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O’Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 480
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease
Öğüş, A. C., Yoldaş, B., Ozdemir, T., Uğuz, A., Olcen, S., Keser, İ., Coşkun, M., Çilli, A., & Yeğin, O. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00061703 · Cited by 423
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis
Cooper, A. M., & Khader, S. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00702.x · Cited by 357
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis
Cavalcanti, Y. V. N., de Castro, M. C. A. B., Neves, J. K. D. A. L., Ferraz, J. C., & Pereira, V. R. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/745483 · Cited by 341
Innate Immune Gene Polymorphisms in Tuberculosis
Azad, A. K., Sadée, W., & Schlesinger, L. S. (2012) · Infection and Immunity · doi:10.1128/iai.00443-12 · Cited by 313
Maglione, P. J., Xu, J., & Chan, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7222 · Cited by 308
Role of innate cytokines in mycobacterial infection
Cooper, A. M., Mayer-Barber, K. D., & Sher, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.13 · Cited by 309
Maartens, G., & Wilkinson, R. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61262-8 · Cited by 263
The two faces of interleukin 10 in human infectious diseases
Mège, J., Meghari, S., Honstettre, A., Capo, C., & Raoult, D. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70577-1 · Cited by 257
Host Innate Immune Response to Mycobacterium tuberculosis
Bhatt, K., & Salgame, P. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9084-0 · Cited by 223
A wearable haemodialysis device for patients with end-stage renal failure: a pilot study
Davenport, A., Gura, V., Ronco, C., Beizai, M., Ezon, C., & Rambod, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61864-9 · Cited by 218
Berrington, W. R., & Hawn, T. R. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00545.x · Cited by 200
Control of human host immunity to mycobacteria
Ottenhoff, T. H. M., Verreck, F. A. W., Hoeve, M. A., & van de Vosse, E. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.09.011 · Cited by 179
Pro- and anti-inflammatory cytokines in tuberculosis: A two-edged sword in TB pathogenesis
Etna, M. P., Giacomini, E., Severa, M., & Coccia, E. M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.011 · Cited by 178
Genetic susceptibility to infectious disease
Segal, S., & Hill, A. V. S. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00207-5 · Cited by 158
Jamieson, S., Miller, E. N., Black, G. F., Peacock, C. S., Cordell, H. J., Howson, J. M. M., Shaw, M. ‐., Burgner, D. P., Xu, W., Lins-Lainson, Z., et al. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364029 · Cited by 148
Self-citationGenetic susceptibility in tuberculosis
Yim, J., & Selvaraj, P. (2010) · Respirology · doi:10.1111/j.1440-1843.2009.01690.x · Cited by 141
Innate immune responses to mycobacteria and the downregulation of atopic responses
Rook, G. A. W., Martinelli, R., & Brunet, L. R. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200310000-00003 · Cited by 136
Polymorphism within the Interferon-γ/Receptor Complex is Associated with Pulmonary Tuberculosis
Cooke, G., Campbell, S. J., Sillah, J. S., Gustafson, P., Bah, B., Sirugo, G., Bennett, S., McAdam, K. P. W. J., Sow, O. Y., Lienhardt, C., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-088oc · Cited by 132
Self-citationLi, X., Yang, Y., Zhou, F., Zhang, Y., Lu, H., Jin, Q., & Gao, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015831 · Cited by 126
Past, present and future directions in human genetic susceptibility to tuberculosis
Möller, M., de Wit, E., & Hoal, E. G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00600.x · Cited by 130
Brancusi, F., Farrar, J., & Heemskerk, D. (2012) · Future Microbiology · doi:10.2217/fmb.12.86 · Cited by 124
SLC11 family of H + -coupled metal-ion transporters NRAMP1 and DMT1
Mackenzie, B., & Hediger, M. A. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1141-9 · Cited by 127
Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease
Malik, S., Abel, L., Tooker, H. R., Poon, A. H., Simkin, L., Girard, M., Adams, G. J., Starke, J. R., Smith, K. C., Graviss, E. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503368102 · Cited by 122
Kumar, N. P., Sridhar, R., Banurekha, V. V., Jawahar, M. S., Fay, M. P., Nutman, T. B., & Babu, S. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201305-112oc · Cited by 119
T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection
Moreira-Teixeira, L., Redford, P. S., Stavropoulos, E., Ghilardi, N., Maynard, C. L., Weaver, C. T., do Rosário, A. P. F., Wu, X., Langhorne, J., & O’Garra, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601340 · Cited by 122
SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan
Mohamed, H. S., Ibrahim, M. E., Miller, E. N., White, J. K., Cordell, H. J., Howson, J. M. M., Peacock, C. S., Khalil, E. A. G., Hassan, A. M. E., & Blackwell, J. M. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201089 · Cited by 106
Self-citationInfluence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility
Harishankar, M., Selvaraj, P., & Bethunaickan, R. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00213 · Cited by 103
Sirugo, G., Hennig, B. J., Adeyemo, A., Matimba, A., Newport, M. J., Ibrahim, M. E., Ryckman, K. K., Tacconelli, A., Mariani‐Costantini, R., Novelli, G., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0511-y · Cited by 96
Self-citationMapping of a Novel Susceptibility Locus Suggests a Role for MC3R and CTSZ in Human Tuberculosis
Cooke, G., Campbell, S. J., Bennett, S., Lienhardt, C., McAdam, K. P. W. J., Sirugo, G., Sow, O. Y., Gustafson, P., Mwangulu, F., van Helden, P. D., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1554oc · Cited by 88
Self-citationOpposing roles of IL-10 in acute bacterial infection
Peñaloza, H. F., Schultz, B. M., Nieto, P. A., Salazar, G. A., Suazo, I. D., González, P. A., Riedel, C. A., Álvarez-Lobos, M. M., Kalergis, A. M., & Bueno, S. M. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.07.003 · Cited by 88
Newport, M. J., Allen, A., Awomoyi, A. A., Dunstan, S. J., McKinney, E., Marchant, A., & Sirugo, G. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.02.001 · Cited by 83
Self-citationThe TB pandemic: an old problem seeking new solutions
Meya, D. B., & Mcadam, K. P. W. J. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01795.x · Cited by 82
Self-citationGenetic Susceptibility to Tuberculosis
Bellamy, R. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.02.006 · Cited by 83
Genetic Epidemiology of Tuberculosis Susceptibility: Impact of Study Design
Stein, C. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001189 · Cited by 82
Immune Vulnerability of Infants to Tuberculosis
Driessche, K. V., Persson, A., Marais, B. J., Fink, P. J., & Urdahl, K. B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/781320 · Cited by 83
Hoal, E. G., Lewis, L., Jamieson, S., Tanzer, F., Rossouw, M., Victor, T., Hillerman, R., Beyers, N., Blackwell, J. M., & van Helden, P. D. (2004) · PubMed · Cited by 77
Self-citationMcHenry, M. L., Bartlett, J., Igo, R. P., Wampande, E. M., Benchek, P. H., Mayanja‐Kizza, H., Fluegge, K., Hall, N. B., Gagneux, S., Tishkoff, S. A., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008728 · Cited by 79
Stein, C. M., Zalwango, S. K., Chiunda, A. B., Millard, C., Leontiev, D. V., Horvath, A., Cartier, K. C., Chervenak, K. A., Boom, W. H., Elston, R. C., et al. (2007) · Human Genetics · doi:10.1007/s00439-007-0357-8 · Cited by 67
Stober, C. B., Brode, S., White, J. K., Popoff, J.-F., & Blackwell, J. M. (2007) · Infection and Immunity · doi:10.1128/iai.00153-07 · Cited by 68
Self-citationMotsinger‐Reif, A. A., Antas, P. R. Z., Oki, N. O., Levy, S., Holland, S. M., & Sterling, T. R. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-37 · Cited by 66
Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland
Dubaniewicz, A., Jamieson, S. E., Dubaniewicz-Wybieralska, M., Fakiola, M., Miller, E. N., & Blackwell, J. M. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201370 · Cited by 63
Self-citationHost genetics and tuberculosis : Theory of genetic polymorphism and tuberculosis.
Aravindan, P. P. (2019) · Lung India · doi:10.4103/0970-2113.257707 · Cited by 62
Nramp1‐functionality increases iNOS expression via repression of IL‐10 formation
Fritsche, G., Nairz, M., Werner, E. R., Barton, H. C., & Weiss, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838449 · Cited by 57
Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis Mramp
Wagner, D., Maser, J. M., Morić, I., Boéchat, N., Vogt, S., Gicquel, B., Lai, B. C. H., Reyrat, J., & Bermudez, L. E. (2005) · Microbiology · doi:10.1099/mic.0.27213-0 · Cited by 57
Family Relationship, Water Contact and Occurrence of Buruli Ulcer in Benin
Sopoh, G. E., Barogui, Y. T., Johnson, R. C., Dossou, A. D., Makoutodé, M., Anagonou, S., Kestens, L., & Portaels, F. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000746 · Cited by 56
Archer, N., Nassif, N. T., & O’Brien, B. A. (2015) · Genes and Immunity · doi:10.1038/gene.2015.8 · Cited by 52
Weiss, D. J., & Souza, C. D. (2008) · Veterinary Pathology · doi:10.1354/vp.45-6-829 · Cited by 50
Fitzgerald, D. W., Sterling, T. R., & Haas, D. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00250-2 · Cited by 49
Human genes in TB infection: their role in immune response
Lykouras, D., Sampsonas, F., Kaparianos, A., Karkoulias, K., Tsoukalas, G., & Spiropoulos, K. V. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2008.408 · Cited by 46
Genetic control of susceptibility to bacterial infections in mouse models
Lam-Yuk-Tseung, S., & Gros, P. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00276.x · Cited by 47
The Role of Host Genetics (and Genomics) in Tuberculosis
Naranbhai, V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0011-2016 · Cited by 45
Mekonnen, E., Bekele, E., & Stein, C. M. (2018) · Global Health · doi:10.1017/gheg.2017.17 · Cited by 45
Awomoyi, A. A. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00231.x · Cited by 44
Self-citationHistorical statistics support a hypothesis linking tuberculosis and air pollution caused by coal.
Tremblay, G. (2007) · PubMed · Cited by 44
Awomoyi, A. A., Charurat, M., Marchant, A., Miller, E. N., Blackwell, J. M., McAdam, K. P. W. J., & Newport, M. J. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110050401 · Cited by 43
Self-citationGenetics and visceral leishmaniasis in the Sudan: seeking a link
Blackwell, J. M., Mohamed, H. S., & Ibrahim, M. E. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.04.003 · Cited by 43
Self-citationAwomoyi, A. A. (2004) · Thorax · doi:10.1136/thx.2003.013029 · Cited by 43
Self-citationHost genome polymorphisms and tuberculosis infection: What we have to say?
Khalilullah, S. A., Harapan, H., Hasan, N. A., Winardi, W., Ichsan, I., & Mulyadi, M. (2013) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2013.12.002 · Cited by 42
Winkler, S., Necek, M., Winkler, H., Adégnika, A. A., Perkmann, T., Ramharter, M., & Kremsner, P. G. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.020 · Cited by 42
Mehta, J., & Dutt, A. K. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0018-2016 · Cited by 42
Genomics of Human Pulmonary Tuberculosis: from Genes to Pathways
Stein, C. M., Sausville, L. N., Wejse, C. M., Sobota, R. S., Zetola, N. M., Hill, P. C., Boom, W. H., Scott, W. K., Sirugo, G., & Williams, S. M. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0130-9 · Cited by 40
Bandaru, A., Rakh, S. S., Ishaq, M., Murthy, K. J. R., & Valluri, V. L. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31816099e6 · Cited by 39
Pereira, C. B., Palaci, M., Leite, O. H. M., Duarte, A. J. S., & Benard, G. (2003) · Microbes and Infection · doi:10.1016/j.micinf.2003.10.007 · Cited by 39
Sakthianandeswaren, A., Curtis, J., Elso, C. M., Kumar, B., Baldwin, T. M., Lopaticki, S., Kedzierski, Ł., Smyth, G. K., Foote, S. J., & Handman, E. (2010) · Infection and Immunity · doi:10.1128/iai.00126-10 · Cited by 38
Oki, N. O., Motsinger‐Reif, A. A., Antas, P. R. Z., Levy, S., Holland, S. M., & Sterling, T. R. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-28 · Cited by 36
Antas, P. R. Z., Ding, L., Hackman, J., REEVESHAMMOCK, L., Shintani, A., Schiffer, J., Holland, S. M., & Sterling, T. R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.042 · Cited by 33
Perl, D. P., Fogarty, U., Harpaz, N., & Sachar, D. B. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200411000-00022 · Cited by 35
Therapeutic potential of carbohydrates as regulators of macrophage activation
Lundahl, M. L. E., Scanlan, E. M., & Lavelle, E. C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.09.003 · Cited by 33
Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection
Khajoee, V., Saito, M., Takada, H., Nomura, A., Kusuhara, K., Yoshida, S.-I., Yoshikai, Y., & Hara, T. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02985.x · Cited by 31
SLC11A1 promoter gene polymorphisms and fibrosis progression in chronic hepatitis C
Romero‐Gómez, M., Montes-Cano, M. A., Otero-Fernández, M. A., Torres, B., Sánchez-Muñoz, D., Aguilar, F., Barroso, N., Izquierdo, L. G., Castellano-Megias, V. M., Núñez-Roldán, A., et al. (2004) · Gut · doi:10.1136/gut.2003.028274 · Cited by 31
Honeycutt, J. D., Wenner, N., Li, Y., Brewer, S. M., Massis, L. M., Brubaker, S. W., Chairatana, P., Owen, S. V., Canals, R., Hinton, J. C. D., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008763 · Cited by 33
Roupie, V., Rosseels, V., Piersoel, V., Zinniel, D. K., Barletta, R. G., & Huygen, K. (2008) · Infection and Immunity · doi:10.1128/iai.01137-07 · Cited by 29
Elemental analysis of the Mycobacterium avium phagosome in Balb/c mouse macrophages
Wagner, D., Maser, J. M., Morić, I., Vogt, S., Kern, W. V., & Bermudez, L. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.048 · Cited by 29
Newport, M. J., Awomoyi, A. A., & Blackwell, J. M. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01328.x · Cited by 29
Self-citationBobadilla, K., Sada, E., Jaime, M. E., González, Y., Ramachandra, L., Rojas, R. E., Pedraza‐Sánchez, S., Michalak, C., González‐Noriega, A., & Torres, M. (2012) · Immunology · doi:10.1111/imm.12010 · Cited by 28
No evidence for association between SLC11A1and visceral leishmaniasis in India
Mehrotra, S., Oommen, J., Mishra, A., Sudarshan, M., Tiwary, P., Jamieson, S. E., Fakiola, M., Rani, D. S., Kumarasamy Thangaraj, K., Rai, M., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-71 · Cited by 28
Self-citationMihret, A., Loxton, A. G., Bekele, Y., Kaufmann, S. H. E., Kidd, M., Haks, M. C., Ottenhoff, T. H. M., Aseffa, A., Howe, R., & Walzl, G. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-257 · Cited by 27
Cassidy, J. P., & Martineau, A. R. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.08.001 · Cited by 26
Genetics of susceptibility to tuberculosis in humans
Newport, M. J., & Nejentsev, S. (2004) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2004.707 · Cited by 25
Self-citationΤaka, S., Liandris, E., Gazouli, M., Sotirakoglou, Κ., Théodoropoulos, G., Bountouri, M., Ανδρεάδου, Μ., & Ikonomopoulos, J. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.03.033 · Cited by 24
Transcription factor ATF-3 regulates allele variation phenotypes of the human SLC11A1 gene
Τaka, S., Gazouli, M., Politis, P. K., Pappa, K. I., & Anagnou, N. P. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2289-1 · Cited by 23
Gallant, C. J., Malik, S., Jabado, N., Cellier, M. F., Simkin, L., Finlay, B. B., Graviss, E. A., Gros, P., Musser, J. M., & Schurr, E. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364435 · Cited by 23
Tuberculosis as a complex trait: impact of genetic epidemiological study design
Stein, C. M., & Baker, A. R. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9301-7 · Cited by 23
Fernández, R. D. V., Díaz, A., Bongiovanni, B., Gallucci, G., Bértola, D., Gardeñez, W., Lioi, S., Bertolin, Y., Galliano, R., Bay, M. L., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00126 · Cited by 21
Lam-Yuk-Tseung, S., Picard, V., & Gros, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601828200 · Cited by 21
Tong, X., Wan, Q., Li, Z., Liu, S., Huang, J., Wu, M., & Fan, H. S. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.04.023 · Cited by 21
Young, B. N., Rendón, A., Rosas-Taraco, A. G., Baker, J., Healy, M. E., Gross, J., Long, J. C., Burgos, M. V., & Hunley, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094303 · Cited by 22
Innate (General or Nonspecific) Host Defense Mechanisms
Dieffenbach, C. W., & Tramont, E. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00004-7 · Cited by 21
Hunting for immune response regulatory genes: vaccination studies in infant twins
Newport, M. J., Goetghebuer, T., & Marchant, A. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.5.739 · Cited by 21
Self-citationHost genetics and tuberculosis susceptibility
Selvaraj, P. (2004) · NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) · Cited by 20
O’Brien, B. A., Archer, N., Simpson, A. M., Torpy, F. R., & Nassif, N. T. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.02.002 · Cited by 19
Braun, K., Wolfe, J. N., Kiazyk, S. A. K., & Sharma, M. K. (2015) · BMC Genetics · doi:10.1186/s12863-015-0224-x · Cited by 17
IL-10 Dampens the Th1 and Tc Activation through Modulating DC Functions in BCG Vaccination
Xu, H., Jia, Y., Li, Y., Wei, C., Wang, W., Guo, R. H., Jia, J., Wu, Y. H., Li, Z., Wei, Z., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/8616154 · Cited by 17
Are mouse models of human mycobacterial diseases relevant? Genetics says: ‘yes!’
Apt, A. S. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03472.x · Cited by 17
Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen
Hwang, S., Welsh, K. J., Boyd, S., Kruzel, M. L., & Actor, J. K. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.10.017 · Cited by 16
Metadata
- Authors
- Awomoyi, A. A., Marchant, A., Howson, J. M. M., McAdam, K. P. W. J., Blackwell, J. M., & Newport, M. J.
- Affiliations
- MRC Unit the Gambia (GM)
- John Radcliffe Hospital (GB)
- Addenbrooke's Hospital (GB)
- Corresponding author
- Awomoyi, Agnes A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-15
- Volume
- 186
- Issue
- 12
- Pages
- 1808-1814
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2171429463
- Cited by
- 153
- References
- 54
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 11 · 2012: 9
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Figshare (submittedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion)
- Funders
- Alexander and Margaret Stewart Trust
- Wellcome Trust (065642)
- Sir Halley Stewart Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- tuberculosis susceptibility, SLC11A1, NRAMP1, IL-10, genetic polymorphism, host genetic factors, monocytes, lipopolysaccharide, innate immunity, intracellular pathogens
- MeSH terms
- Natural Resistance-associated Macrophage Protein 1, Adult, Alleles, Gambia, Genotype, Humans, Immunity, Innate, Male, Middle Aged, Monocytes, Mycobacterium tuberculosis, Polymorphism, Genetic, Tuberculosis, Pulmonary, Case-Control Studies, Interleukin-10, Genetic Predisposition to Disease, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review